SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSigmaroc. Regulatory News (SRC)

Share Price Information for Sigmaroc. (SRC)

Share Price is delayed by 15 minutes
Get Live Data
124.00    4.70 (3.94%)
Bid:
124.00
Ask:
124.30
Spread: 0.30 (0.242%)
Market Cap: £1.38b
SRC Live PriceLast checked at - London Stock Exchange

Intraday Sigmaroc. Share Chart

Trading Update

29 Jul 2022 07:00

RNS Number : 1517U
SigmaRoc PLC
29 July 2022
 

29 July 2022

 

(EPIC: SRC / Market: AIM / Sector: Construction Materials)

 

SIGMAROC PLC

 ('SigmaRoc', the 'Group' or the 'Company')

 

Trading update H1 2022 - Positive trading momentum

 

SigmaRoc, the specialist quarried materials group, is pleased to announce strong H1 2022 trading, with good momentum carried into H2 2022.

 

Highlights:

 

- Strong first half of 2022, demonstrating the effectiveness of the Group's diversified model;

- H1 revenue of £248m, up 18% over 2021 on an adjusted like-for-like basis;

- H1 underlying EBITDA of £48m, up 6% over 2021;

- Underlying EPS over 3.6p, up approximately 35% over the prior period;

- Continued good cash generation, with leverage within the Group's target range;

- Diversified market profile and good demand leave the Group well placed to deliver the Board's expectations for 2022.

 

The Group delivered H1 revenue of £248m, representing an 18% like-for-like increase over the same period last year. First half EBITDA was £48m, ahead 6% on a like-for-like basis over H1 2021, giving an 19.2% EBITDA margin for the period which benefited from the effectiveness of contractual pass through mechanisms, dynamic pricing and continued cost management.

 

Underlying EPS for the half year was over 3.6p, representing an increase of more than 35% from H1 2021, demonstrating the value accretion from the Nordkalk acquisition and effectiveness of the Group's operational improvement programmes. The Group has continued to generate cash and following the completion of the Johnston acquisition in Q1 2022, leverage has reduced to 2.2x at the end of H1 2022, within the Group's target range.

 

Outlook

 

Trading in the early part of H2 2022 has started well, with the Group benefitting from its broad end market and geographical diversification. Demand remains good both for housing and infrastructure related demand, as well as for industrial minerals. The Group has successfully dealt with the various supply chain and inflationary headwinds in H1 2022, with further improvement initiatives planned for H2 2022.

 

The Group expects to publish its 2022 interim results by 12 September 2022.

 

Max Vermorken, CEO of SigmaRoc, commented:

 

"To state the obvious this was a first half unlike any other, yet the Group performed extremely well. Input cost increases were managed and further cost reduction initiatives were implemented. We closed H1 2022 with a strong performance and remain encouraged by the demand outlook in all segments for the months ahead. Our focus remains squarely on developing our Group in terms of products and geography and we remain very confident in delivering good financial and strategic progress both in the current year and over the medium term."

 

 

Information on the Company is available on its website, www.sigmaroc.com.

 

SigmaRoc plc

Max Vermorken

 

Tel: +44 (0) 207 002 1080

Liberum Capital (Co-Broker and Nominated Adviser)

Neil Patel / Jamie Richards / Ben Cryer

Tel: +44 (0) 203 100 2000

 

 

Peel Hunt (Co-Broker)

Mike Bell / Ed Allsopp

 

Tel: +44 (0) 20 7418 8900

Investor Relations

Dean Masefield

Tel: +44 (0) 207 002 1080

ir@sigmaroc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUGAMUPPGAR
Date   Source Headline
15th Jun 20267:00 amRNSShare Purchase by Director
2nd Jun 202610:27 amRNSTR-1: Notification of Major Holdings
1st Jun 20261:51 pmRNSTR-1: Notification of Major Holdings
30th Apr 20263:37 pmRNSAGM Result
30th Apr 20267:00 amRNSAGM Statement
20th Apr 20267:00 amRNSTR-1: Notification of Major Holdings
9th Apr 20263:21 pmRNSPDMR Dealing
31st Mar 20267:00 amRNSNew debt facility
26th Mar 20267:00 amRNSShare Purchases by Director
19th Mar 20267:00 amRNSShare Purchases by Directors
18th Mar 20269:55 amRNSEmployee Benefit Trust Share Purchase
16th Mar 202610:58 amRNSAnnouncement of Option and LTIP awards
16th Mar 202610:58 amRNSAnnouncement of Option and LTIP awards
16th Mar 20267:00 amRNSFull Year Results and Notice of AGM
16th Mar 20267:00 amRNSFull Year Results and Notice of AGM
10th Mar 20265:52 pmRNSTR-1: Notification of Major Holdings
10th Mar 20265:52 pmRNSTR-1: Notification of Major Holdings
3rd Mar 20268:00 amRNS-RSkreenHouse Litherm
3rd Mar 20267:00 amRNSNotice of Results
23rd Feb 20263:59 pmRNSTR-1: Notification of Major Holdings
28th Jan 20263:40 pmRNSTR-1: Notification of Major Holdings
23rd Jan 20267:00 amRNSExercise of options and sale of shares by PDMRs
19th Jan 20267:00 amRNSYear-end trading update
7th Jan 202611:25 amRNSTR-1: Notification of Major Holdings
17th Dec 20255:41 pmRNSTR-1: Notification of Major Holdings
25th Nov 202512:06 pmRNSTR-1: Notification of Major Holdings
21st Oct 20257:00 amRNSQ3 Trading Update
16th Sep 20257:00 amRNSUpdate in relation to the AMeLi project
8th Sep 20257:25 amRNSInterim Results
27th Aug 20257:00 amRNSTR-1: Notification of Major Holdings
12th Aug 20252:57 pmRNSTR-1: Notification of Major Holdings
11th Aug 20251:17 pmRNSTR-1: Notification of Major Holdings
6th Aug 20253:51 pmRNSTR-1: Notification of Major Holdings
24th Jul 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
15th Jul 20257:00 amRNSTR-1: Notification of Major Holdings
11th Jul 20259:45 amRNSHolding(s) in Company
9th Jul 20253:16 pmRNSHolding(s) in Company
3rd Jul 20253:28 pmRNSTR-1: Notification of Major Holdings
10th Jun 20259:15 amRNS-RSeed funding of Koncrete
15th May 202511:48 amRNSDirector/PDMR Shareholding
7th May 20257:00 amRNSCapital Markets Day
1st May 20254:01 pmRNSAGM Result
1st May 20257:00 amRNSAGM Statement
25th Apr 20257:00 amRNS-RPartnership with Adaptavate
10th Apr 20252:18 pmRNSAwards under SIP to Directors and PDMRs
1st Apr 20257:00 amRNSNotice of AGM and Posting of Annual Report
20th Mar 202510:29 amRNSTR-1: Notification of Major Holdings
17th Mar 20257:01 amRNSCapital Markets Day
17th Mar 20257:00 amRNSFull Year Results
27th Feb 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.